These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 4011844)

  • 1. The clinical spectrum of acute glomerulonephritis and lung haemorrhage (Goodpasture's syndrome).
    Holdsworth S; Boyce N; Thomson NM; Atkins RC
    Q J Med; 1985 Apr; 55(216):75-86. PubMed ID: 4011844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease.
    Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD
    J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Goodpasture's syndrome associated with pulmonary eosinophilic vasculitis.
    Komadina KH; Houk RW; Vicks SL; Desrosier KF; Ridley DJ; Boswell RN
    J Rheumatol; 1988 Aug; 15(8):1298-301. PubMed ID: 3184080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasculitis in Goodpasture's syndrome.
    Wu MJ; Rajaram R; Shelp WD; Beirne GJ; Burkholder PM
    Arch Pathol Lab Med; 1980 Jun; 104(6):300-2. PubMed ID: 6892868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and morphological aspects of the management of crescentic anti-glomerular basement membrane antibody (anti-GBM) nephritis/Goodpasture's syndrome.
    Walker RG; Scheinkestel C; Becker GJ; Owen JE; Dowling JP; Kincaid-Smith P
    Q J Med; 1985 Jan; 54(213):75-89. PubMed ID: 3975346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Course and prognosis of anti-basement membrane antibody (anti-BM-Ab)-mediated disease: report of 35 cases.
    Merkel F; Pullig O; Marx M; Netzer KO; Weber M
    Nephrol Dial Transplant; 1994; 9(4):372-6. PubMed ID: 8084449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Goodpasture's syndrome with normal renal function.
    Bailey RR; Simpson IJ; Lynn KL; Neale TJ; Doak PB; McGiven AR
    Clin Nephrol; 1981 Apr; 15(4):211-5. PubMed ID: 7237870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and outcomes of patients with Goodpasture's syndrome.
    Shah MK; Hugghins SY
    South Med J; 2002 Dec; 95(12):1411-8. PubMed ID: 12597309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single autoantigen in Goodpasture's syndrome identified by a monoclonal antibody to human glomerular basement membrane.
    Pusey CD; Dash A; Kershaw MJ; Morgan A; Reilly A; Rees AJ; Lockwood CM
    Lab Invest; 1987 Jan; 56(1):23-31. PubMed ID: 3540450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Goodpasture's disease in the absence of circulating anti-glomerular basement membrane antibodies as detected by standard techniques.
    Salama AD; Dougan T; Levy JB; Cook HT; Morgan SH; Naudeer S; Maidment G; George AJ; Evans D; Lightstone L; Pusey CD
    Am J Kidney Dis; 2002 Jun; 39(6):1162-7. PubMed ID: 12046026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and classification of Goodpasture's disease (anti-GBM).
    Hellmark T; Segelmark M
    J Autoimmun; 2014; 48-49():108-12. PubMed ID: 24456936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of kidney-bound antibodies in Goodpasture's syndrome.
    Saxena R; Bygren P; Butkowski R; Wieslander J
    Clin Exp Immunol; 1989 Oct; 78(1):31-6. PubMed ID: 2805421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Variable presentation of antiglomerular basement membrane (anti-GBM) disease: rapid recognition vitally important].
    van Galen KP; Oswald LM; van den Aardweg JG; Stam F; van den Berg JG; Bax WA
    Ned Tijdschr Geneeskd; 2009; 153():B365. PubMed ID: 19785783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-basement-membrane antibody mediated, rapidly progressive, glomerulonephritis. Diagnostic and therapeutic strategy based on a retrospective study of 14 cases].
    Bouget J; Le Pogamp P; Perrier G; Ramée MP; Rivalan J; Camus C; Thomas R; Chevet D
    Ann Med Interne (Paris); 1990; 141(5):409-15. PubMed ID: 2256583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of plasma exchange and immunosuppression to improve renal function in Goodpasture's syndrome.
    McLeish KR; Maxwell DR; Luft FC
    Clin Nephrol; 1978 Aug; 10(2):71-3. PubMed ID: 699402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting edge issues in Goodpasture's disease.
    Chan AL; Louie S; Leslie KO; Juarez MM; Albertson TE
    Clin Rev Allergy Immunol; 2011 Oct; 41(2):151-62. PubMed ID: 21207195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A patient with Goodpasture's syndrome revealed a poor prognosis regardless of receiving intensive therapy from an early stage after onset].
    Hidaka S; Kaneda K; Shite S; Ohkuma K; Yoshimatsu H; Horita M; Miyazaki E; Takebayashi S; Sakata T
    Nihon Jinzo Gakkai Shi; 1996 Feb; 38(2):103-8. PubMed ID: 8717313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of both anti-GBM and immune complex mediated pathogenesis in the initial phase of Goodpasture's syndrome.
    Pasternack A; Törnroth T; Linder E
    Clin Nephrol; 1978 Feb; 9(2):77-85. PubMed ID: 147761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staphylococcal protein A immunoadsorption for Goodpasture's syndrome in four Chinese patients.
    Hu W; Liu Z; Ji D; Xie H; Gong D; Li L
    J Nephrol; 2006; 19(3):312-7. PubMed ID: 16874690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute necrotizing capillaritis in an adolescent dying from a a Goodpasture-like pulmonary-renal syndrome].
    Maresi E; Becchina G; Orlando E; Ottoveggio G
    Pathologica; 1995 Dec; 87(6):666-71. PubMed ID: 8927428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.